Archives

by in
Entry Author Date Location
Relypsa Gets Another $50M for Drug to Fight Excess Potassium 08/13/12 San Francisco
Tolerx Shutters, Courtagen Gets $8M, OvaScience Emerges, & More Boston-Area Life Sciences News 10/14/11 Boston
Report: Tolerx Folds Its Tent, After $150M in Investment and a Failed Diabetes Drug Trial 10/07/11 Boston
Tolerx and Glaxo Diabetes Drug Disappoints in Late-Stage Study 03/11/11 Boston
Relypsa Snags $70M Venture Round to Get Rid of Excess Potassium in Blood 09/13/10 San Francisco
Olympus Acquires Redmond’s Spiration, Maker of Lung-Disease Valve, for Undisclosed Sum 06/25/10 Seattle
Tolerx, After a Decade and $150M, Eagerly Awaits Data from Big Diabetes Trial 03/04/10 Boston
Aviir Lands $1,000,000 New Financing Round 10/20/09 San Francisco
Spiration Pulls in $7M Debt Financing For Device to Treat Lung Diseases 09/30/09 Seattle
TradeBeam Holdings Obtains $7,000,000 New Round 09/21/09 San Francisco
Calix Networks Obtains $100,000,000 New Funding Round 08/31/09 San Francisco
XDx Receives $14,400,000 New Round 08/05/09 San Francisco
Relypsa Lands $10,000,000 Series A Financing Round 03/11/09 San Francisco
NeuroVista, Emerging from Stealth Mode, Unveils Technology to Predict Epileptic Seizures 07/28/08 Seattle
Aurora Networks Obtains New Round 06/30/08 San Francisco
Can ToleRx Escape the Autoimmunity-Drug-Development Deathtrap? 09/28/07 Boston
Spine Wave Inc. Secures $45,000,000 Series D Round 04/10/07 Boston
Page 1 of 1